National Guideline Clearinghouse | Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

full-text ►

National Guideline Clearinghouse | Recommendations for drug therapies for relapsing-remitting multiple sclerosis.





Canadian Agency for Drugs and Technologies in Health

Guideline Title

Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

Bibliographic Source(s)

Canadian Agency for Drugs and Technologies in Health (CADTH). Recommendations for drug therapies for relapsing-remitting multiple sclerosis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH); 2013 Oct. 19 p. [44 references]

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.